# Evaluate Analgesic / Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain

> **NCT01495858** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 267 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Naproxen Sodium 440 mg / DPH 25 mg (BAY98-7111)
- **DRUG:** Naproxen Sodium 440 mg (BAYH6689)
- **DRUG:** DPH 50 mg

## Key facts

- **NCT ID:** NCT01495858
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 267 (ACTUAL)
- **Last updated:** 2015-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01495858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01495858, "Evaluate Analgesic / Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT01495858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*